J

JPS Health Network | Behavioral Health Service

Research site

(Unclaimed)

Location

1617 Hemphill Street, Fort Worth, Texas, United States of America

Site insights

Top conditions

Top treatments

Stannsoporfin

Palbociclib

RO6889450

Ralmitaront

PB2452

Bentracimab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 17 total trials

Benefits of µCor in Ambulatory Decompensated Heart Failure (BMADHF)

Subjects meeting the inclusion/exclusion criteria will wear the µCor for at least 90 days. During the study, clinic follow up will occur every 30 day...

Active, not recruiting

Heart Failure

Device: µCor

Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT)

This is a multi-center, open-label, prospective single-arm study of reversal of the antiplatelet effects of ticagrelor with bentracimab (PB2452) in p...

Enrolling

Hemorrhage

Invasive Procedure

Drug: Bentracimab (PB2452) Infusion

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

To evaluate the safety and efficacy of intravenous (IV) administration of bone marrow mesenchymal stem cell derived extracellular vesicles (EVs), Exo...

Enrolling

Acute Respiratory Distress Syndrome

ARDS

Biological: ExoFlo

Other: Intravenous normal saline

Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

The purpose of this study is to compare the efficacy and safety of intravenous (IV) infusions of MT-3921 to placebo in subjects with acute traumatic...

Enrolling

Spinal Cord Injury

Biological: Placebo

Biological: MT-3921